Structures by: Zia-ur-Rehman M.
Total: 70
<i>N</i>-[2-(Aminocarbonyl)phenyl]-4-hydroxy-2<i>H</i>-1,2-benzothiazine- 3-carboxamide 1,1-dioxide dimethyl sulfoxide solvate
C16H13N3O5S,C2H6OS
Acta Crystallographica Section E (2007) 63, 11 o4215-o4216
a=8.8314(5)Å b=9.1405(5)Å c=24.5041(14)Å
α=90.00° β=96.499(2)° γ=90.00°
4-Hydroxy-4,6a,6b,9,9,12a,14b-heptamethylperhydropicen-3-one hemihydrate
C29H48O2,0.5(H2O)
Acta Crystallographica Section E (2008) 64, 1 o264-o264
a=6.4432(4)Å b=57.477(8)Å c=7.2226(6)Å
α=90.00° β=114.725(5)° γ=90.00°
<i>N</i>'-(2,4-Dinitrophenyl)acetohydrazide
C8H8N4O5
Acta Crystallographica Section E (2008) 64, 8 o1441
a=4.8585(4)Å b=10.7703(8)Å c=19.1059(14)Å
α=90.00° β=90.00° γ=90.00°
Methyl 2-acetonyl-4-hydroxy-2<i>H</i>-1,2-benzothiazine-3-carboxylate 1,1-dioxide
C13H13NO6S
Acta Crystallographica Section E (2008) 64, 8 o1392
a=11.7982(3)Å b=8.7206(2)Å c=13.2474(4)Å
α=90.00° β=90.00° γ=90.00°
4-<i>n</i>-Butyl-3-(3-methylphenyl)-1<i>H</i>-1,2,4-triazol-5(4<i>H</i>)-one
C13H17N3O
Acta Crystallographica Section E (2008) 64, 8 o1388
a=16.905(5)Å b=18.139(5)Å c=8.145(2)Å
α=90.00° β=90.00° γ=90.00°
Methyl 4-ethoxy-2-methyl-2<i>H</i>-1,2-benzothiazine-3-carboxylate 1,1-dioxide
C13H15NO5S
Acta Crystallographica Section E (2008) 64, 8 o1508
a=7.9810(4)Å b=8.1215(4)Å c=10.8173(6)Å
α=89.4783(7)° β=79.5124(8)° γ=79.3434(7)°
N-(4-Chloro-2-nitrophenyl)methanesulfonamide
C7H7ClN2O4S
Acta Crystallographica Section E (2008) 64, 10 o2034-o2035
a=11.728(3)Å b=4.9798(13)Å c=17.988(5)Å
α=90.00° β=107.334(8)° γ=90.00°
5-Amino-1-phenyl-1<i>H</i>-pyrazole-4-carboxylic acid
C10H9N3O2
Acta Crystallographica Section E (2008) 64, 7 o1312-o1313
a=3.7937(5)Å b=21.613(3)Å c=11.1580(16)Å
α=90.00° β=92.170(2)° γ=90.00°
<i>N</i>-(4-Chloro-2-nitrophenyl)-<i>N</i>-(methylsulfonyl)acetamide
C9H9ClN2O5S
Acta Crystallographica Section E (2008) 64, 11 o2092
a=9.8071(4)Å b=9.4310(4)Å c=13.5679(7)Å
α=90.00° β=105.883(2)° γ=90.00°
N-[2-(Aminocarbonyl)phenyl]-4-hydroxy-2-methyl-2H-1,2-benzothiazine- 3-carboxamide-1,1-dioxide dimethyl sulfoxide solvate
C17H15N3O5S,C2H6OS
Acta Crystallographica Section E (2007) 63, 2 o900-o901
a=8.4973(2)Å b=10.1959(4)Å c=12.0545(4)Å
α=92.132(2)° β=101.540(2)° γ=95.550(2)°
1-(4-Hydroxy-2-methyl-1,1-dioxo-2<i>H</i>-1,2-benzothiazin-3-yl)ethanone
C11H11NO4S
Acta Crystallographica Section E (2008) 64, 5 o788
a=6.85230(10)Å b=8.3222(2)Å c=10.4880(2)Å
α=72.1321(11)° β=77.9619(12)° γ=80.0360(12)°
Methyl 2-(benzenesulfonamido)acetate
C9H11NO4S
Acta Crystallographica Section E (2009) 65, 6 o1204
a=9.7268(8)Å b=5.0781(4)Å c=10.9286(9)Å
α=90.00° β=100.087(3)° γ=90.00°
2-(Prop-2-enyl)-1,2-benzisothiazol-3(2<i>H</i>)-one 1,1-dioxide
C10H9NO3S
Acta Crystallographica Section E (2009) 65, 6 o1236
a=7.2169(8)Å b=7.8347(7)Å c=10.3849(12)Å
α=105.530(3)° β=91.586(3)° γ=112.047(3)°
2-[(Methylsulfonyl)amino]benzoic acid
C8H9NO4S
Acta Crystallographica Section E (2009) 65, 10 o2453
a=5.2001(2)Å b=8.6120(4)Å c=11.2314(5)Å
α=72.675(3)° β=84.155(3)° γ=86.846(3)°
<i>N</i>-[2-(Aminocarbonyl)phenyl]-4-hydroxy-2-methyl-2<i>H</i>-1,2-benzothiazine-3-carboxamide 1,1-dioxide
C17H15N3O5S
Acta Crystallographica Section E (2009) 65, 10 o2596
a=8.1377(6)Å b=7.0515(6)Å c=29.069(2)Å
α=90.00° β=96.502(3)° γ=90.00°
Piperidinium 4-hydroxy-3-(methoxycarbonyl)-1,2-benzothiazin-2-ide 1,1-dioxide
C5H12N,C10H8NO5S,
Acta Crystallographica Section E (2009) 65, 10 o2451
a=12.0423(5)Å b=9.1791(3)Å c=14.5193(5)Å
α=90.00° β=90.556(2)° γ=90.00°
3,5-Dimethyl-2,6-diphenyl-3,4,5,6-tetrahydro-2<i>H</i>-pyran-4-one
C19H20O2
Acta Crystallographica Section E (2009) 65, 3 o463
a=14.7247(10)Å b=9.2803(7)Å c=23.0393(16)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(3,4-Dimethylphenyl)-4-hydroxy-2-methyl-2<i>H</i>-1,2-benzothiazine-3- carboxamide 1,1-dioxide
C18H18N2O4S
Acta Crystallographica Section E (2009) 65, 4 o900-o901
a=7.5458(4)Å b=8.0214(3)Å c=14.4832(7)Å
α=89.864(3)° β=79.530(2)° γ=73.812(3)°
2-(Benzenesulfonamido)acetic acid
C8H9NO4S
Acta Crystallographica Section E (2008) 64, 12 o2283-o2284
a=8.5181(3)Å b=11.1302(4)Å c=10.6414(4)Å
α=90.00° β=112.600(2)° γ=90.00°
<i>N</i>-(2,3-Dimethylphenyl)-4-hydroxy-2-methyl-2<i>H</i>-1,2-benzothiazine- 3-carboxamide 1,1-dioxide
C18H18N2O4S
Acta Crystallographica Section E (2009) 65, 3 o644-o645
a=10.2461(3)Å b=8.5421(2)Å c=19.8944(5)Å
α=90.00° β=104.8320(10)° γ=90.00°
4-{[(4-Methylphenyl)sulfonyl]amino}benzoic acid
C14H13N1O4S1
Acta Crystallographica Section E (2011) 67, 4 o1018
a=5.1588(2)Å b=6.9277(2)Å c=20.0350(6)Å
α=83.5740(10)° β=86.3570(10)° γ=72.8240(10)°
<i>N</i>-Cyclohexyl-<i>N</i>-propylbenzenesulfonamide
C15H23NO2S
Acta Crystallographica Section E (2009) 65, 12 o3165
a=8.5532(3)Å b=11.6877(4)Å c=15.4410(5)Å
α=90.00° β=90.649(2)° γ=90.00°
2-Methyl-5-nitrobenzenesulfonamide
C7H8N2O4S
Acta Crystallographica Section E (2010) 66, 1 o136
a=4.9872(4)Å b=6.2814(5)Å c=28.557(2)Å
α=90.00° β=90.00° γ=90.00°
Methyl 2-ethyl-4-hydroxy-2<i>H</i>-1,2-benzothiazine-3-carboxylate 1,1-dioxide
C12H13NO5S
Acta Crystallographica Section E (2010) 66, 5 o1070
a=7.2460(6)Å b=20.548(2)Å c=8.5710(8)Å
α=90.00° β=90.00° γ=90.00°
1-Ethyl-<i>N</i>'-[(<i>E</i>)-4-hydroxybenzylidene]-7-methyl-4-oxo-1,4- dihydro-1,8-naphthyridine-3-carbohydrazide
C19H18N4O3
Acta Crystallographica Section E (2009) 65, 4 o860-o861
a=7.6437(2)Å b=13.3290(2)Å c=17.2212(4)Å
α=90.000000° β=98.1745(14)° γ=90.000000°
Ethyl 5-amino-1-(4-chloro-2-nitrophenyl)-1<i>H</i>-pyrazole-4-carboxylate
C12H11ClN4O4
Acta Crystallographica Section E (2009) 65, 2 o275-o276
a=8.5899(8)Å b=10.2413(9)Å c=15.6633(14)Å
α=90.00° β=96.5415(13)° γ=90.00°
<i>N</i>-(4-Methoxy-2-nitrophenyl)-<i>N</i>-(methylsulfonyl)acetamide
C10H12N2O6S
Acta Crystallographica Section E (2009) 65, 5 o941
a=7.1512(2)Å b=15.4303(5)Å c=11.3217(3)Å
α=90.00° β=91.769(2)° γ=90.00°
2-[(2<i>E</i>)-3-Phenylprop-2-en-1-yl]-1,2-benzisothiazol-3(2<i>H</i>)-one 1,1-dioxide
C16H13NO3S
Acta Crystallographica Section E (2009) 65, 5 o1011
a=6.9375(5)Å b=7.1579(4)Å c=29.673(2)Å
α=90.00° β=96.160(4)° γ=90.00°
<i>N</i>-Cyclohexyl-<i>N</i>-ethylbenzenesulfonamide
C14H21NO2S
Acta Crystallographica Section E (2009) 65, 11 o2867
a=18.1950(10)Å b=12.9799(7)Å c=12.7327(6)Å
α=90.00° β=108.587(3)° γ=90.00°
4-Hydroxy-<i>N</i>-(2,4,6-tribromophenyl)-2<i>H</i>-1,2-benzothiazine-3-carboxamide 1,1-dioxide
C15H9Br3N2O4S
Acta Crystallographica Section E (2009) 65, 12 o2998
a=7.5082(4)Å b=8.7486(6)Å c=13.0669(9)Å
α=83.618(2)° β=86.280(2)° γ=87.684(2)°
Methyl 4-hydroxy-2-propyl-2<i>H</i>-1,2-benzothiazine-3-carboxylate 1,1-dioxide
C13H15NO5S
Acta Crystallographica Section E (2009) 65, 12 o3025
a=12.4398(6)Å b=8.7538(5)Å c=12.7288(7)Å
α=90.00° β=90.00° γ=90.00°
Methyl 4-hydroxy-2-(prop-2-en-1-yl)-2<i>H</i>-1,2-benzothiazine-3-carboxylate 1,1-dioxide
C13H13NO5S
Acta Crystallographica Section E (2009) 65, 12 o3077
a=12.4289(10)Å b=8.3706(8)Å c=13.0132(11)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-Benzyl-<i>N</i>-cyclohexylbenzenesulfonamide
C19H23NO2S
Acta Crystallographica Section E (2009) 65, 12 o3053
a=9.1996(5)Å b=11.0406(5)Å c=17.1897(9)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>'-[(<i>E</i>)-Benzylidene]-1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carbohydrazide
C19H18N4O2
Acta Crystallographica Section E (2009) 65, 12 o3152-o3153
a=7.16420(10)Å b=8.83830(10)Å c=14.4560(2)Å
α=82.624(6)° β=85.454(7)° γ=68.594(5)°
<i>N</i>-Cyclohexyl-<i>N</i>-(prop-2-en-1-yl)benzenesulfonamide
C15H21NO2S
Acta Crystallographica Section E (2009) 65, 12 o3102
a=8.4911(5)Å b=11.4176(6)Å c=15.6274(10)Å
α=90.00° β=94.188(3)° γ=90.00°
<i>N</i>-Benzyl-<i>N</i>-cyclohexyl-4-methylbenzenesulfonamide
C20H25NO2S
Acta Crystallographica Section E (2009) 65, 12 o3109
a=9.0702(4)Å b=11.1054(5)Å c=18.1971(8)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-cyclohexyl-<i>N</i>-ethylbenzenesulfonamide
C14H21NO2S
Acta Crystallographica Section E (2009) 65, 12 o3107
a=8.3837(4)Å b=11.4467(5)Å c=15.1488(7)Å
α=90.00° β=92.541(2)° γ=90.00°
3,6-Dimethyl-<i>o</i>-phenylenedimethanol
C10H14O2
Acta Crystallographica Section E (2010) 66, 1 o189
a=9.5821(7)Å b=8.7184(7)Å c=11.7522(9)Å
α=90.00° β=107.810(4)° γ=90.00°
Methyl 2-methyl-4-(oxiran-2-ylmethoxy)-2<i>H</i>-1,2-benzothiazine-3-carboxylate 1,1-dioxide
C14H15NO6S
Acta Crystallographica Section E (2010) 66, 2 o333
a=7.2007(3)Å b=12.8435(6)Å c=15.7820(7)Å
α=90.00° β=96.5250(7)° γ=90.00°
<i>N</i>'-[(<i>E</i>)-4-(Diethylamino)benzylidene]-4-nitrobenzohydrazide monohydrate
C18H20N4O3,H2O
Acta Crystallographica Section E (2010) 66, 4 o1007-o1008
a=38.3142(12)Å b=7.4563(3)Å c=12.6332(5)Å
α=90.00° β=98.215(2)° γ=90.00°
4-Nitro-<i>N</i>'-[(<i>E</i>)-3-pyridylmethylidene]benzohydrazide
C13H10N4O3
Acta Crystallographica Section E (2010) 66, 4 o976
a=14.6158(3)Å b=8.1969(2)Å c=10.3645(2)Å
α=90.00° β=100.6090(10)° γ=90.00°
<i>N</i>'-(3-Methoxybenzylidene)-4-nitrobenzohydrazide monohydrate
C15H13N3O4,H2O
Acta Crystallographica Section E (2010) 66, 4 o977-o978
a=6.7162(3)Å b=7.4929(3)Å c=32.1141(15)Å
α=91.883(2)° β=91.5697(12)° γ=112.753(2)°
(2<i>E</i>)-3-(2-Chloro-6-methyl-3-quinolyl)-1-(1-naphthyl)prop-2-en-1-one
C23H16ClNO
Acta Crystallographica Section E (2010) 66, 4 o761
a=16.919(8)Å b=7.146(3)Å c=14.829(5)Å
α=90.00° β=103.29(2)° γ=90.00°
Methyl 2-(1,1,3-trioxo-2,3-dihydro-1,2-benzothiazol-2-yl)acetate
C10H9NO5S
Acta Crystallographica Section E (2010) 66, 5 o1028
a=8.9418(4)Å b=12.7595(6)Å c=10.3145(5)Å
α=90.00° β=107.3000(10)° γ=90.00°
<i>N</i>-(4-Hydroxyphenyl)benzenesulfonamide
C12H11NO3S
Acta Crystallographica Section E (2010) 66, 5 o1088
a=5.1072(2)Å b=9.3948(4)Å c=24.0903(10)Å
α=90.00° β=90.00° γ=90.00°
4-Nitro-<i>N'</i>-[(1<i>E</i>,2<i>E</i>)-3-phenylprop-2-en-1- ylidene]benzohydrazide
C16H13N3O3
Acta Crystallographica Section E (2010) 66, 5 o1022
a=16.4236(17)Å b=5.3360(5)Å c=17.1073(18)Å
α=90.00° β=114.578(5)° γ=90.00°
(<i>E</i>)-3-(3-Chlorophenyl)-1-(4-methoxyphenyl)prop-2-en-1-one
C16H13ClO2
Acta Crystallographica Section E (2010) 66, 6 o1346-o1347
a=10.3415(6)Å b=3.89380(10)Å c=16.9152(10)Å
α=90.00° β=107.582(2)° γ=90.00°
3-[4-(Acetamido)benzenesulfonamido]benzoic acid
C15H14N2O5S
Acta Crystallographica Section E (2011) 67, 1 o25-o26
a=7.9829(3)Å b=8.4143(3)Å c=12.6554(5)Å
α=70.888(2)° β=81.553(2)° γ=77.104(2)°
6-Bromo-4-hydrazinylidene-1-methyl-3<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C9H10BrN3O2S
Acta Crystallographica Section E (2011) 67, 8 o2078
a=10.1483(5)Å b=9.6375(4)Å c=11.2118(5)Å
α=90.00° β=92.278(2)° γ=90.00°
Methyl 2-benzyl-4-hydroxy-1,1-dioxo-1,2,3,4-tetrahydro-1λ^6^,2-benzothiazine-3-carboxylate
C17H15NO5S
Acta Crystallographica Section E (2011) 67, 7 o1588-o1589
a=9.4920(15)Å b=10.9607(17)Å c=15.050(2)Å
α=90.00° β=99.758(2)° γ=90.00°
4-Hydrazinylidene-1-methyl-3<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C9H11N3O2S
Acta Crystallographica Section E (2011) 67, 8 o2038
a=6.6643(2)Å b=9.6834(3)Å c=15.5890(5)Å
α=90.00° β=97.6990(10)° γ=90.00°
Methyl 1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate monohydrate
C13H14N2O3,H2O
Acta Crystallographica Section E (2012) 68, 3 o630-o631
a=4.69890(10)Å b=23.7246(7)Å c=11.3635(3)Å
α=90.00° β=91.6460(10)° γ=90.00°
Methyl 2-(but-3-enyl)-4-hydroxy-1,1-dioxo-2<i>H</i>-1λ^6^,2-benzothiazine-3-carboxylate
C14H15NO5S
Acta Crystallographica Section E (2012) 68, 6 o1926
a=25.265(8)Å b=8.929(3)Å c=12.584(4)Å
α=90.00° β=90.00° γ=90.00°
Methyl 4-hydroxy-2-methoxycarbonylmethyl-1,1-dioxo-1,2-dihydro-1λ^6^,2-benzothiazine-3-carboxylate
C13H13NO7S
Acta Crystallographica Section E (2011) 67, 9 o2527
a=8.9128(14)Å b=12.414(2)Å c=13.443(2)Å
α=79.784(2)° β=72.981(3)° γ=88.503(3)°
6-Bromo-4-(2-cyclohexylidenehydrazin-1-ylidene)-1-methyl-2,2-dioxo-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine
C15H18BrN3O2S
Acta Crystallographica Section E (2012) 68, 7 o2088-o2089
a=9.9357(2)Å b=11.2614(3)Å c=15.8263(3)Å
α=110.6250(10)° β=91.525(3)° γ=102.879(4)°
1-Methyl-4-[1-(1-phenylethylidene)-hydrazin-2-ylidene]-3,4-dihydro-1<i>H</i>- 2λ^6^,1-benzothiazine-2,2-dione
C17H17N3O2S
Acta Crystallographica Section E (2012) 68, 7 o2100
a=6.6678(2)Å b=12.0783(6)Å c=20.0529(8)Å
α=90.00° β=90.00° γ=90.00°
2-{(<i>E</i>)-[(2<i>Z</i>)-(3-Chloro-1-methyl-2,2-dioxo-3,4-dihydro- 1<i>H</i>-2,1-benzothiazin-4-ylidene)hydrazinylidene]methyl}phenol
C16H14ClN3O3S
Acta Crystallographica Section E (2012) 68, 2 o307
a=7.0973(5)Å b=12.0957(7)Å c=18.7396(13)Å
α=90.00° β=96.058(4)° γ=90.00°
1,3-Diethyl-2-sulfanylidene-5-(2,4,5-trimethoxybenzylidene)-1,3-diazinane-4,6-dione
C18H22N2O5S
Acta Crystallographica Section E (2013) 69, 1 o49
a=7.97110(10)Å b=17.4106(3)Å c=13.5265(2)Å
α=90.00° β=99.237(2)° γ=90.00°
Methyl 4-hydroxy-2-isopropyl-1,1-dioxo-2<i>H</i>-1,2-benzothiazine-3-carboxylate
C13H15NO5S
Acta Crystallographica Section E (2011) 67, 7 o1823-o1824
a=11.3896(6)Å b=9.8421(5)Å c=12.7680(7)Å
α=90.00° β=105.7820(10)° γ=90.00°
6-Bromo-1-methyl-4-[2-(4-methylbenzylidene)hydrazinylidene]-3<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C17H16BrN3O2S
Acta Crystallographica Section E (2011) 67, 8 o2092
a=9.1077(6)Å b=6.8328(4)Å c=14.1765(9)Å
α=90.00° β=96.807(3)° γ=90.00°
<i>N</i>'-[(<i>E</i>)-1-(4-Bromophenyl)ethylidene]-4-hydroxy-2-methyl-1,1-dioxo-2<i>H</i>-1,2-benzothiazine-3-carbohydrazide
C18H16BrN3O4S
Acta Crystallographica Section E (2011) 67, 10 o2613
a=14.692(2)Å b=16.562(2)Å c=7.5254(10)Å
α=90.00° β=104.8200(10)° γ=90.00°
2-Imino-3-(2-nitrophenyl)-1,3-thiazolidin-4-one
C9H7N3O3S
Acta Crystallographica Section E (2011) 67, 10 o2564
a=7.3036(5)Å b=16.4409(10)Å c=8.2455(5)Å
α=90.00° β=102.1321(9)° γ=90.00°
Methyl 4-hydroxy-1,1-dioxo-2-(2-phenylethyl)-2<i>H</i>-1λ^6^,2-benzothiazine-3-carboxylate
C18H17NO5S
Acta Crystallographica Section E (2011) 67, 12 o3445
a=9.018(2)Å b=19.026(4)Å c=10.193(2)Å
α=90.00° β=106.441(3)° γ=90.00°
3,4-Dimethylpyrano[2,3-<i>c</i>]pyrazol-6(2<i>H</i>)-one
C8H8N2O2
Acta Crystallographica Section E (2012) 68, 4 o1217
a=13.6219(3)Å b=6.8766(2)Å c=16.2369(4)Å
α=90.00° β=96.091(2)° γ=90.00°
Methyl 2-butyl-4-hydroxy-1,1-dioxo-2<i>H</i>-1,2-benzothiazine-3-carboxylate
C14H17NO5S
Acta Crystallographica Section E (2012) 68, 6 o1663
a=25.173(7)Å b=9.280(2)Å c=12.531(3)Å
α=90.00° β=91.741(3)° γ=90.00°
2-(3,4-Dimethyl-5,5-dioxo-2<i>H</i>,4<i>H</i>- pyrazolo[4,3-<i>c</i>][1,2]benzothiazin-2-yl)acetic acid
C13H13N3O4S
Acta Crystallographica Section E (2012) 68, 6 o1970-o1971
a=10.495(4)Å b=8.415(2)Å c=15.136(6)Å
α=90.00° β=91.034(19)° γ=90.00°
2-(3,4-Dimethyl-5,5-dioxo-2<i>H</i>,4<i>H</i>-pyrazolo[4,3- <i>c</i>][1,2]benzothiazin-2-yl)-<i>N</i>-(3-methoxybenzyl)acetamide
C21H22N4O4S
Acta Crystallographica Section E (2012) 68, 11 o3064-o3065
a=8.65410(10)Å b=25.8809(3)Å c=18.3892(2)Å
α=90.00° β=92.2080(10)° γ=90.00°
Propan-2-yl 2-(1,1,3-trioxo-2,3-dihydro-1λ^6^,2-benzothiazol-2-yl)acetate
C12H13NO5S
Acta Crystallographica Section E (2012) 68, 9 o2761
a=8.0922(3)Å b=9.2314(4)Å c=17.7414(8)Å
α=90.00° β=100.075(2)° γ=90.00°
Ethyl 2-(3,4-dimethyl-5,5-dioxo-1<i>H</i>,4<i>H</i>- benzo[<i>e</i>]pyrazolo[4,3-<i>c</i>][1,2]thiazin-1-yl)acetate
C15H17N3O4S
Acta Crystallographica Section E (2012) 68, 10 o3010
a=8.3027(2)Å b=8.5915(3)Å c=22.3476(7)Å
α=90.00° β=90.674(2)° γ=90.00°
4-Methyl-3-phenyl-2,4-dihydropyrazolo[4,3-<i>c</i>][1,2]benzothiazine 5,5-dioxide
C16H13N3O2S
Acta Crystallographica Section E (2012) 68, 9 o2615-o2616
a=12.1028(5)Å b=16.3934(7)Å c=7.0962(3)Å
α=90.00° β=90.00° γ=90.00°